Distribution of nontuberculous Mycobacteria among presumptive drug resistance tuberculosis patients from a ministry of health drug resistance surveillance program, in western Kenya.

INTRODUCTION

Nontuberculous Mycobacteria (NTM) species are emerging pathogens causing Pulmonary diseases with no definitive treatment. Molecular techniques enable characterization and drug resistance profiling, this study sought to determine NTM prevalence, circulating species, and distribution factors among presumptive multidrug-resistant tuberculosis (MDR-TB) patients in western Kenya.

METHOD

Sputum samples were collected between March through October 2022, and transported for testing at Kenya Medical Research Institute (KEMRI) TB laboratory, in Kisumu. The standard NALC-NaOH MGIT culture technique, smear, HAIN AS/CM and NTM drug resistance were carried out.

RESULTS

Of the 155 specimens analyzed, 106 (68.4 %) were males, 41 (26.5 %) HIV positive, and participants of ages 36-45 years, the majority. An overall NTM prevalence of 99 (63.9 %), of whom 63 (63 %) among males reported. In addition, 11 NTM species identified, with (44, 44 %).

CONCLUSIONS

High prevalence of NTM species was observed among middle-aged males and HIV negative participants, Kisumu led in distribution (29 %) and among HIV positive. The NTM prevalence among smear negative vs smear positive, was significant a p < 0.001, hence adequate TB/HIV integration and management, use of molecular techniques, and accurate identification is critical.